Functional surgery versus amputation for in situ or minimally invasive nail melanoma: A meta-analysis - 12/09/19
Abstract |
Background |
Evidence on whether functional surgery is not inferior to amputation for the treatment of in situ or minimally invasive (Breslow thickness ≤0.5 mm) nail melanoma is limited.
Objective |
To investigate the difference in local recurrence between the 2 interventions for in situ or minimally invasive nail melanoma using available published studies.
Methods |
We performed systematic search on PubMed, Embase, Cochrane Library, trial registers, and grey literature databases from inception to June 28, 2018. We included observational studies with at least 5 patients with in situ or minimally invasive nail melanoma. Main outcome was local recurrence.
Results |
The odds ratio synthesized from 5 studies including 109 patients (88 functional operations and 21 amputations) was 1.57 (95% confidence interval, 0.31-8.00).
Limitations |
Small sample size and possible interstudy heterogeneity.
Conclusions |
Our meta-analysis revealed no difference in local recurrence between the 2 interventions. Considering the functional deficit after amputation, conservative surgery should be the treatment of choice for in situ or minimally invasive nail melanoma.
Le texte complet de cet article est disponible en PDF.Key words : amputation, conservative surgery, functional surgery, melanoma, melanoma in situ, meta-analysis, nail disease, recurrence
Abbreviations used : CI, FS, MINM, NM, NMIS, OR, RoBANS
Plan
| Drs Jo and Cho authors contributed equally to this work. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| This study was presented as a poster at the 14th European Association of Dermato-Oncology Congress and 9th World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers, Barcelona, Spain, November 6-9, 2018. |
|
| Reprints not available from the authors. |
Vol 81 - N° 4
P. 917-922 - octobre 2019 Retour au numéro
Article précédent
- Factors associated with time to surgery in melanoma: An analysis of the National Cancer Database
- Marissa L.H. Baranowski, Howa Yeung, Suephy C. Chen, Theresa W. Gillespie, Michael Goodman
- Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study
- Megan H. Noe, Marilyn T. Wan, Daniel B. Shin, April W. Armstrong, Kristina Callis Duffin, Zelma C. Chiesa Fuxench, Robert E. Kalb, Alan Menter, Eric L. Simpson, Junko Takeshita, Stephen K. Tyring, Abby S. Van Voorhees, Nehal N. Mehta, Joel M. Gelfand
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?